TFA
RNAM

Transamerica Financial Advisors’s Avidity Biosciences RNAM Stock Holding History

Transamerica Financial Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33
Closed -$2.38K – 2071
2025
Q4 		$2.38K Hold
33
– – ﹤0.01% 1099
2025
Q3 		$1.44K Buy
+33
New +$1.33K ﹤0.01% 1109

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Transamerica Financial Advisors's RNAM Position: Q1 2026 in Review

Transamerica Financial Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 33 shares — an estimated $2.38K sold.

Transamerica Financial Advisors first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $2.38K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Transamerica Financial Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Transamerica Financial Advisors sold 33 Avidity Biosciences shares in Q1 2026, an estimated $2.38K.
  • Transamerica Financial Advisors first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • Transamerica Financial Advisors's Avidity Biosciences position peaked at $2.38K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.